A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer

Autor: Planchard, David, Wolf, Jürgen, Solomon, Benjamin, Sebastian, Martin, Wermke, Martin, Heist, Rebecca S., Sun, Jong-Mu, Min Kim, Tae, Reguart, Noemi, Sanmamed, Miguel F., Felip, Enriqueta, Garrido, Pilar, Santoro, Armando, Bootle, Douglas, Couillebault, Xuân-Mai, Gaur, Anil, Mueller, Christina, Poggio, Teresa, Yang, Jie, Moschetta, Michele, Dooms, Christophe
Zdroj: In Lung Cancer November 2024 197
Databáze: ScienceDirect
Externí odkaz: